Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study-Reference-Cited by-同舟云学术

Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study

Published:2013-10-29 Issue:3 Volume:16 Page:262-267
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Barker A.¹,Lauria A.²,Schloot N.³,Hosszufalusi N.⁴,Ludvigsson J.⁵,Mathieu C.⁶,Mauricio D.⁷,Nordwall M.⁵⁸,Van der Schueren B.⁶,Mandrup-Poulsen T.⁹,Scherbaum W. A.¹⁰,Weets I.¹¹¹²,Gorus F. K.¹¹¹²,Wareham N.¹,Leslie R. D.¹³,Pozzilli P.²¹³

Affiliation:

1. Department MRC Epidemiology Unit, Cambridge Institute of Public Health; Cambridge UK

2. Department of Endocrinology and Diabetes; University Campus Bio-Medico; Rome Italy

3. Institute for Clinical Diabetology, German Diabetes Centre; Leibniz-Institute for Diabetes Research and Clinic for Metabolic Diseases Heinrich Heine University; Dusseldorf Germany

4. 3rd Department of Internal Medicine; Semmelweis University; Budapest Hungary

5. Division of Pediatrics, Department of Clinical and Experimental Medicine Faculty of Health Sciences; Linköping University; Linköping Sweden

6. Laboratory for Experimental Medicine and Endocrinology; Katholieke Universiteit Leuven; Leuven Belgium

7. Department of Endocrinology; Hospital Arnau de Vilanova; Lleida Spain

8. Pediatric Clinic; Vrinnevi Hospital; Norrköping Sweden

9. Department of Biomedical Sciences; University of Copenhagen; Copenhagen Denmark

10. Department of Endocrinology, Diabetes & Rheumatology; Heinrich Heine University; Dusseldorf Germany

11. Diabetes Research Center and Academic Hospital (UZ Brussel); Vrije Universiteit Brussel (VUB); Brussel Belgium

12. Belgian Diabetes Registry (BDR); Brussels Belgium

13. Centre of Diabetes, Blizard Institute, Barts and The London School of Medicine; Queen Mary University of London; London UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12216/fullpdf

Reference40 articles.

1. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001;Palmer;Diabetes,2004

2. D-Cure Workshop Challenges in developing endpoints for type 1 diabetes intervention studies;Cernea;Diabetes Metab Res Rev,2009

3. C-peptide an adequate endpoint in type 1 diabetes;Ludvigsson;Diabetes Metab Res Rev,2009

4. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial;The Diabetes Control and Complications Trial Research Group;Ann Intern Med,1998

5. Type 1 diabetes mellitus in 2011: heterogeneity of T1DM raises questions for therapy;Pozzilli;Nat Rev Endocrinol,2011

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic discovery and risk prediction for type 1 diabetes in individuals without high-risk HLA-DR3/DR4 haplotypes;2023-11-12

2. A Review on Latent Autoimmune Diabetes in Adults;Cureus;2023-10-29

3. The challenges of identifying and studying type 1 diabetes in adults;Diabetologia;2023-09-20

4. Tip 1 Diabetes Mellitus Tanılı Hastalarda Poliglandüler Otoimmün Sendrom Sıklığının Tespiti ve Diyabetin Prognoz ve Komplikasyonları ile İlişkisinin Araştırılması;Turkish Journal of Diabetes and Obesity;2023-08-31

5. Insights on C-peptide in diabetes;IP Journal of Nutrition, Metabolism and Health Science;2023-07-15